CPIG
RCUS icon

Chicago Partners Investment Group’s Arcus Biosciences RCUS Stock Holding History

Chicago Partners Investment Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-150
Closed -$1K – 774
2018
Q3 		$1K Hold
150
– – ﹤0.01% 1036
2018
Q2 		$2K Hold
150
– – ﹤0.01% 920
2018
Q1 		$2K Buy
+150
New +$2.5K ﹤0.01% 900

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Partners Investment Group's RCUS Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of Arcus Biosciences (RCUS) in Q4 2018, closing a stake of 150 shares — an estimated $1K sold.

Chicago Partners Investment Group first reported a position in RCUS in Q1 2018 and held it in 3 quarters. The position peaked at $2K in Q2 2018. 67 funds tracked by Wall St. Rank hold RCUS as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining Arcus Biosciences position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 150 Arcus Biosciences shares in Q4 2018, an estimated $1K.
  • Chicago Partners Investment Group first reported a position in Arcus Biosciences in Q1 2018 and held it in 3 quarters.
  • Chicago Partners Investment Group's Arcus Biosciences position peaked at $2K in Q2 2018.
  • 67 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.